
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.3
229229 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
9,053 Listeners
8,504 Listeners
1,869 Listeners
988 Listeners
2,854 Listeners
1,020 Listeners
7,736 Listeners
1,006 Listeners
3,463 Listeners
1,377 Listeners
19,751 Listeners
10,638 Listeners
5,650 Listeners
54 Listeners
2,256 Listeners
2,019 Listeners
23,949 Listeners
10,050 Listeners
553 Listeners
7,539 Listeners
2,380 Listeners
1,286 Listeners
5,441 Listeners
1,193 Listeners
410 Listeners
5,368 Listeners
15,110 Listeners
59 Listeners
46 Listeners
94 Listeners
5 Listeners
0 Listeners